TGFB1 and neoplasm: The transforming growth factor-β (TGF-β) signalling pathway is highly activated in advanced PDAC and is associated with poor prognosis by promoting the epithelial-to-mesenchymal transition (EMT) and angiogenesis, maintaining tumour stem cell characteristics, and matrix metalloprotease (MMP) activity [11–16].